This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n6http://linked.opendata.cz/ontology/domain/vavai/
n4http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F65269705%3A_____%2F10%3A%230001018%21RIV11-MZ0-65269705/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n17http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F65269705%3A_____%2F10%3A%230001018%21RIV11-MZ0-65269705
rdf:type
n6:Vysledek skos:Concept
dcterms:description
Splenomegaly belongs among typical findings on physical examination in patients with newly diagnosed chronic myelogenous leukemia (CML). Its disappearance is a part of achieving complete hematological response (CHR), that is nowadays (when second generation of tyrosine kinase inhibitors are available) of particular interest during imatinib treatment. Splenomegaly belongs among typical findings on physical examination in patients with newly diagnosed chronic myelogenous leukemia (CML). Its disappearance is a part of achieving complete hematological response (CHR), that is nowadays (when second generation of tyrosine kinase inhibitors are available) of particular interest during imatinib treatment.
dcterms:title
Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia
skos:prefLabel
Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia
skos:notation
RIV/65269705:_____/10:#0001018!RIV11-MZ0-65269705
n3:aktivita
n13:V n13:Z
n3:aktivity
V, Z(MSM0021622430), Z(MSM6198959205)
n3:cisloPeriodika
5
n3:dodaniDat
n17:2011
n3:domaciTvurceVysledku
n11:3715434 n11:4376285 n11:4585623 n11:1344153
n3:druhVysledku
n16:J
n3:duvernostUdaju
n14:S
n3:entitaPredkladatele
n12:predkladatel
n3:idSjednocenehoVysledku
278569
n3:idVysledku
RIV/65269705:_____/10:#0001018
n3:jazykVysledku
n9:eng
n3:klicovaSlova
splenomegaly
n3:klicoveSlovo
n7:splenomegaly
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[0D4206D87853]
n3:nazevZdroje
American Journal of Hematology
n3:obor
n15:FD
n3:pocetDomacichTvurcuVysledku
4
n3:pocetTvurcuVysledku
9
n3:rokUplatneniVysledku
n17:2010
n3:svazekPeriodika
85
n3:tvurceVysledku
Ráčil, Zdeněk Žáčková, Daniela Mayer, Jiří Rázga, Filip
n3:wos
000277325800022
n3:zamer
n4:MSM6198959205 n4:MSM0021622430
s:issn
0361-8609
s:numberOfPages
3